Effects of oral glucosamine hydrochloride administration on plasma free amino acid concentrations in dogs

Marine Drugs

Volumn 9, Issue 5, 2011, Pages 712-718

  Azuma, Kazuo ^a   Osaki, Tomohiro ^a   Tsuka, Takeshi ^a   Imagawa, Tomohiro ^a   Okamoto, Yoshiharu ^a   Takamori, Yoshimori ^b   Minami, Saburo ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b Koyo Chemical Co Ltd   (Japan)

Author keywords

Amino acid; Dog; Glucosamine hydrochloride; N acetyl D glucosamine

Indexed keywords

ALANINE; AMINO ACID; GLUCOSAMINE; GLUCOSE; GLUTAMIC ACID; GLYCINE; GLYCOSAMINOGLYCAN; N ACETYLGLUCOSAMINE; PROTEOGLYCAN;

AMINO ACID ANALYSIS; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOG; DOSE TIME EFFECT RELATION; DRUG EFFECT; FOOD INTAKE; NONHUMAN;

CANIS FAMILIARIS;

EID: 79957639819     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md9050712     Document Type: Article

References (17)

1. Gregorym, P.J.; Sperry, M.; Wilson, A.F. Dietary supplements for osteoarthritis. Am. Fam. Physician 2008, 77, 177-184.
2. Minami, S.; Hata, M.; Tamai, Y.; Hashida, M.; Takayama, T.; Yamamoto, S.; Okada, M.; Funatsu, T.; Tsuka, T.; Imagawa, T.; Okamoto, Y. Clinical application of D-glucosamine and scale collagen peptide on canine and feline orthopedic diseases and spondylitis deformans. Carbohydr. Polym. 2010, 84, 831-834.
3. Goodrich, L.R.; Nixon, A.J. Medical treatment of osteoarthritis in the horse-a review. Vet. J. 2006, 171, 51-69. (Pubitemid 43116335)
4. Barclay, T.S.; Tsourounis, C.; McCart, G.M. glucosamine. Ann. Pharmacother. 1998, 32, 574-579.
5. Aghazadeh-Habashi, A.; Sattari, S.; Pasutto, F.; Jamali, F. Single dose pharmacokinetics and bioavailability of glucosamine in the rat. J. Pharm. Pharm. Sci. 2002, 5, 181-184.
6. Adebowale, A.; Du, J.; Liang, Z.; Leslie, J.L.; Eddington, N.D. The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogs. Biopharm. Drug Dispos. 2002, 23, 217-225.
7. Laverty, S.; Sandy, J.D.; Celeste, C.; Vachon, P.; Marier, J.F.; Plaas, A.H. Synovial fluid levels and serum pharmacokinetics in a large animal model following treatment with oral glucosamine at clinically relevant doses. Arthritis Rheum. 2005, 52, 181-191. (Pubitemid 40129247)
8. Du, J.; White, N.; Eddington, N.D. The bioavailability and pharmacokinetics of glucosamine hydrochloride and chondroitin sulfate after oral and intravenous single dose administration in the horse. Biopharm. Drug Dispos. 2004, 25, 109-116.
9. Meulyzer, M.; Vachon, P.; Beaudry, F.; Vinardell, T.; Richard, H.; Beauchamp, G.; Laverty, S. Comparison of pharmacokinetics of glucosamine and synovial fluid levels following administration of glucosamine sulphate or glucosamine hydrochloride. Osteoarthritis Cartilage 2008, 16, 973-979.
10. Shikhman, A.R.; Brinson, D.C.; Valbracht, J.; Lotz, M.K. Differential metabolic effects of glucosamine and N-acetylglucosamine in human articular chondrocytes. Osteoarthritis Cartilage 2009, 17, 1022-1028.
11. Tamai, Y.; Miyatake, K.; Okamoto, Y.; Takamori, Y.; Sakamoto, H.; Minami. S. Enhanced healing of cartilaginous injuries by glucosamine hydrochloride. Carbohydr. Polym. 2002, 48, 369-378.
12. Tamai, Y.; Miyatake, K.; Okamoto, Y.; Takamori, Y.; Sakamoto, K.; Minami, S. Enhanced healing of cartilaginous injuries by N-acetyl-D-glucosamine and glucuronic acid. Carbohydr. Polym. 2002, 54, 251-262.
13. Naito, K.; Watari, T.; Furuhata, A.; Yomogida, S.; Sakamoto, K.; Kurosawa, H.; Kaneko, K.; Nagaoka, I. Evaluation of the effect of glucosamine on an experimental rat osteoarthritis model. Life Sci. 2010, 86, 538-543
14. Tochikubo, O.; Ando, T. Amino Acids and Life-style Related Diseases-Application of New Aminograms in Life Science; Kagawa Nutrition University Publishing Division: Tokyo, Japan, 2010; pp. 52-68.
15. Derfoul, A.; Miyoshi, A.D.; Freeman, D.E.; Tuan, R.S. Glucosamine promotes chondrogenic phenotype in both chondrocytes and mesenchymal stem cells and inhibits MMP-13 expression and matrix degradation. Osteoarthritis Cartilage 2007, 15, 646-655.
16. Reginster, J.Y. Chondromodulation in 2003: dream or reality? Rev. Med. Suisse Romande 2004, 124, 85-87.
17. Deshmukh, K.; Nimni, M.E. Isolation and characterization of cyanogen bromide peptides from the collagen of bovine articular cartilage. Biochem. J. 1973, 133, 615-622.